Skip to main content
. 2018 Jan 4;40(1):38–42. doi: 10.1080/0886022X.2017.1419971

Table 1.

Baseline continuous variables of the study groups.

  Cinacalcet group, N = 23 Control group, N = 101 p value Cinacalcet group with AE, N = 12 Cinacalcet group without AE, N = 11 p value
Age (years) 62 ± 10 68 ± 11 .017 64 ± 8 60 ± 10 .291
Time on HD (years) 13.6 ± 4.9 5.4 ± 5.2 <.001 13.6 ± 4.4 13.5 ± 5.1 .986
Dry weight (kg) 57.3 ± 9.8 54.8 ± 12.9 .380 53.7 ± 7.0 61.2 ± 10.4 .060
Corrected Ca (mg/dL)a 9.3 ± 0.7 9.0 ± 0.7 .036 9.2 ± 0.6 9.3 ± 0.7 .673
Phosphorus (mg/dL) 5.6 ± 1.4 5.0 ± 1.2 .048 5.9 ± 1.5 5.2 ± 1.0 .230
ALP (IU/L) 228 ± 86 265 ± 127 .187 275 ± 91 176 ± 22 .003
Whole PTH (pg/mL) 120 ± 72 87 ± 51 .047 113 ± 23 127 ± 61 .646
Hemoglobin (g/dL) 11.3 ± 1.0 11.1 ± 0.9 .341 11.5 ± 0.7 11.1 ± 1.2 .419
TSAT (%) 19.8 ± 8.8 25.9 ± 11.4 .019 19.7 ± 7.4 20.0 ± 9.8 .925
Ferritin (ng/mL) 101 ± 162 162 ± 268 .293 142 ± 204 55 ± 54 .203
Total protein (g/dL) 6.5 ± 0.4 6.4 ± 0.5 .864 6.5 ± 0.5 6.4 ± 0.4 .379
Albumin (g/dL) 3.9 ± 0.2 3.8 ± 0.3 .011 4.0 ± 0.3 3.9 ± 0.2 .964
BUN (mg/dL) 60.1 ± 11.6 55.2 ± 13.9 .122 60.2 ± 13.0 59.9 ± 9.2 .937
Creatinine (mg/dL) 12.0 ± 2.8 9.5 ± 2.4 <.001 11.3 ± 2.6 12.9 ± 2.7 .177
Kt/Vb 1.6 ± 0.3 1.5 ± 0.3 .039 1.67 ± 0.16 1.59 ± 0.35 .541
Potassium (mEq/L) 5.2 ± 0.7 4.8 ± 0.8 .044 5.2 ± 0.7 5.1 ± 0.7 .664
LDL-C (mg/dL) 96 ± 26 81 ± 26 .013 98.1 ± 21.0 93.7 ± 29.6 .700
β2-MG (mg/L) 27.9 ± 3.7 25.9 ± 6.2 .044 28.2 ± 4.0 27.6 ± 3.2 .745

Values are mean ± SD; AE: adverse events.

a

Corrected Ca = serum calcium + (4-serum albumin); ALP: alkaline phosphatase; PTH: parathyroid hormone; TSAT: transferrin saturation; BUN: blood urea nitrogen; LDL-C: low-density lipoprotein cholesterol; β2-MG: β2-microglobulin.

b

Kt/V calculation is Daugirdas’s formula (1996): spKt/V = ln(R 0.008 × t) + (4 − 3.5 × R) 0.55 × UF/V: in which R is predialysis urea/postdialysis urea, t is dialysis time in hours.